Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis

Incidence of HBV Reactivation in Psoriasis Patients Undergoing Cytokine Inhibitor Therapy: A Single-Center Study and Systematic Review with a Meta-Analysis

Background: Psoriasis patients who are seropositive for hepatitis B surface antigen (HBsAg) or hepatitis B core antibody (HBcAb) face an elevated risk of hepatitis B virus reactivation (HBVr) when treated with cytokine inhibitors. This study aims to elucidate the risk in this population. Methods: A...

Full description

Saved in:
Bibliographic Details
Main Authors: Meng Hsuan Kuo, Ping-Hung Ko, Sz-Tsan Wang, Chih-Wei Tseng
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Viruses
Subjects:
cytokine inhibitors
HBV reactivation
interleukin-17
interleukin-23
psoriasis
Online Access:https://www.mdpi.com/1999-4915/17/1/42
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items